177 related articles for article (PubMed ID: 22921930)
1. Risk factors for development of Clostridium difficile infection due to BI/NAP1/027 strain: a meta-analysis.
Vardakas KZ; Konstantelias AA; Loizidis G; Rafailidis PI; Falagas ME
Int J Infect Dis; 2012 Nov; 16(11):e768-73. PubMed ID: 22921930
[TBL] [Abstract][Full Text] [Related]
2. Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain BI/NAP1/027.
Wieczorkiewicz JT; Lopansri BK; Cheknis A; Osmolski JR; Hecht DW; Gerding DN; Johnson S
Antimicrob Agents Chemother; 2016 Jan; 60(1):418-23. PubMed ID: 26525793
[TBL] [Abstract][Full Text] [Related]
3. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain.
O'Connor JR; Johnson S; Gerding DN
Gastroenterology; 2009 May; 136(6):1913-24. PubMed ID: 19457419
[TBL] [Abstract][Full Text] [Related]
4. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality.
Miller M; Gravel D; Mulvey M; Taylor G; Boyd D; Simor A; Gardam M; McGeer A; Hutchinson J; Moore D; Kelly S
Clin Infect Dis; 2010 Jan; 50(2):194-201. PubMed ID: 20025526
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection.
Garey KW; Sethi S; Yadav Y; DuPont HL
J Hosp Infect; 2008 Dec; 70(4):298-304. PubMed ID: 18951661
[TBL] [Abstract][Full Text] [Related]
7. Prediction of complicated Clostridium difficile infection by pleural effusion and increased wall thickness on computed tomography.
Valiquette L; Pépin J; Do XV; Nault V; Beaulieu AA; Bédard J; Schmutz G
Clin Infect Dis; 2009 Aug; 49(4):554-60. PubMed ID: 19591596
[TBL] [Abstract][Full Text] [Related]
8. Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.
Venugopal AA; Riederer K; Patel SM; Szpunar S; Jahamy H; Valenti S; Shemes SP; Khatib R; Johnson LB
Scand J Infect Dis; 2012 Apr; 44(4):243-9. PubMed ID: 22077148
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin for the treatment of Clostridium difficile Infection: for whom is this expensive bullet really magic?
Pepin J
Clin Infect Dis; 2008 May; 46(10):1493-8. PubMed ID: 18419481
[TBL] [Abstract][Full Text] [Related]
10. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection.
Stevens V; Dumyati G; Fine LS; Fisher SG; van Wijngaarden E
Clin Infect Dis; 2011 Jul; 53(1):42-8. PubMed ID: 21653301
[TBL] [Abstract][Full Text] [Related]
11. Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection.
Citron DM; Babakhani F; Goldstein EJ; Nagaro K; Sambol S; Sears P; Shue YK; Gerding DN
Anaerobe; 2009 Dec; 15(6):234-6. PubMed ID: 19755166
[TBL] [Abstract][Full Text] [Related]
12. Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors.
Debast SB; Vaessen N; Choudry A; Wiegers-Ligtvoet EA; van den Berg RJ; Kuijper EJ
Clin Microbiol Infect; 2009 May; 15(5):427-34. PubMed ID: 19416295
[TBL] [Abstract][Full Text] [Related]
13. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain.
Carignan A; Allard C; Pépin J; Cossette B; Nault V; Valiquette L
Clin Infect Dis; 2008 Jun; 46(12):1838-43. PubMed ID: 18462108
[TBL] [Abstract][Full Text] [Related]
14. Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007.
Weiss K; Boisvert A; Chagnon M; Duchesne C; Habash S; Lepage Y; Letourneau J; Raty J; Savoie M
Infect Control Hosp Epidemiol; 2009 Feb; 30(2):156-62. PubMed ID: 19125681
[TBL] [Abstract][Full Text] [Related]
15. A case-control study of community-associated Clostridium difficile infection.
Wilcox MH; Mooney L; Bendall R; Settle CD; Fawley WN
J Antimicrob Chemother; 2008 Aug; 62(2):388-96. PubMed ID: 18434341
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of hamsters to infection by historic and epidemic BI Clostridium difficile strains during daily administration of three fluoroquinolones.
Phillips ST; Nagaro K; Sambol SP; Johnson S; Gerding DN
Anaerobe; 2011 Aug; 17(4):166-9. PubMed ID: 21511046
[TBL] [Abstract][Full Text] [Related]
17. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis.
Deshpande A; Pasupuleti V; Thota P; Pant C; Rolston DD; Sferra TJ; Hernandez AV; Donskey CJ
J Antimicrob Chemother; 2013 Sep; 68(9):1951-61. PubMed ID: 23620467
[TBL] [Abstract][Full Text] [Related]
18. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.
Garey KW; Dao-Tran TK; Jiang ZD; Price MP; Gentry LO; Dupont HL
J Hosp Infect; 2008 Oct; 70(2):142-7. PubMed ID: 18723249
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and risk factors for Clostridium difficile infection in children.
Sandora TJ; Fung M; Flaherty K; Helsing L; Scanlon P; Potter-Bynoe G; Gidengil CA; Lee GM
Pediatr Infect Dis J; 2011 Jul; 30(7):580-4. PubMed ID: 21233782
[TBL] [Abstract][Full Text] [Related]
20. Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI).
Leav BA; Blair B; Leney M; Knauber M; Reilly C; Lowy I; Gerding DN; Kelly CP; Katchar K; Baxter R; Ambrosino D; Molrine D
Vaccine; 2010 Jan; 28(4):965-9. PubMed ID: 19941990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
